Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

CIK: 0001703031 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $895 (100.0% shares, 0.0% debt)

Holdings (33)

— SPRINGWORKS THERAPEUTICS INC 14.0%

Value ($000) $126 Shares 4,831,307 Est. Cost $21.68 Unrealized —

NUVL NUVALENT INC 11.9%

Value ($000) $107 Shares 3,577,267 Est. Cost $28.96 Unrealized -3.7%

NAMS NEWAMSTERDAM PHARMA COMPANY 10.1%

Value ($000) $90 Shares 8,300,000 Est. Cost $9.95 Unrealized 0.0%

NTRA NATERA INC 6.3%

Value ($000) $56 Shares 1,400,000 Est. Cost $41.20 Unrealized 0.0%

— MERSANA THERAPEUTICS INC 5.7%

Value ($000) $51 Shares 8,663,673 Est. Cost $12.65 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 5.0%

Value ($000) $44 Shares 3,000,000 Est. Cost $26.87 Unrealized -35.0%

CRNX CRINETICS PHARMACEUTICALS IN 4.7%

Value ($000) $42 Shares 2,305,558 Est. Cost $18.69 Unrealized -5.7%

— DYNAVAX TECHNOLOGIES CORP 4.7%

Value ($000) $42 Shares 3,915,000 Est. Cost $9.83 Unrealized —

PHVS PHARVARIS N V 4.0%

Value ($000) $36 Shares 3,180,601 Est. Cost $31.46 Unrealized -83.3%

— CARA THERAPEUTICS INC 3.2%

Value ($000) $29 Shares 2,696,030 Est. Cost $8.97 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 2.9%

Value ($000) $26 Shares 2,364,410 Est. Cost $11.93 Unrealized -29.3%

ANNX ANNEXON INC 2.8%

Value ($000) $25 Shares 4,886,616 Est. Cost $17.41 Unrealized -68.4%

— EQRX INC 2.8%

Value ($000) $25 Shares 10,003,573 Est. Cost $6.82 Unrealized —

— CTI BIOPHARMA CORP 2.5%

Value ($000) $23 Shares 3,777,308 Est. Cost $0.01 Unrealized —

NRIX NURIX THERAPEUTICS INC 2.2%

Value ($000) $20 Shares 1,822,883 Est. Cost $21.10 Unrealized -42.9%

SVRA SAVARA INC 2.0%

Value ($000) $18 Shares 11,622,598 Est. Cost $1.49 Unrealized -7.8%

SLDB SOLID BIOSCIENCES INC 1.9%

Value ($000) $17 Shares 3,130,422 Est. Cost $6.55 Unrealized 0.0%

TNGX TANGO THERAPEUTICS INC 1.6%

Value ($000) $14 Shares 1,921,790 Est. Cost $11.99 Unrealized -41.3%

— 2SEVENTY BIO INC 1.5%

Value ($000) $13 Shares 1,408,901 Est. Cost $18.15 Unrealized —

— X4 PHARMACEUTICALS INC 1.4%

Value ($000) $12 Shares 12,202,510 Est. Cost $2.41 Unrealized —

AVIR ATEA PHARMACEUTICALS INC 1.3%

Value ($000) $12 Shares 2,485,638 Est. Cost $32.23 Unrealized -84.3%

ACAD ACADIA PHARMACEUTICALS INC 1.2%

Value ($000) $11 Shares 701,402 Est. Cost $18.25 Unrealized -14.3%

CCCC C4 THERAPEUTICS INC 1.1%

Value ($000) $10 Shares 1,642,210 Est. Cost $29.00 Unrealized -71.4%

RPID RAPID MICRO BIOSYSTEMS INC 1.1%

Value ($000) $10 Shares 8,434,560 Est. Cost $20.66 Unrealized -88.3%

SYRS SYROS PHARMACEUTICALS INC 0.9%

Value ($000) $8 Shares 2,124,694 Est. Cost $6.27 Unrealized -30.8%

XLO XILIO THERAPEUTICS INC 0.8%

Value ($000) $8 Shares 2,805,413 Est. Cost $17.03 Unrealized -85.9%

— MARINUS PHARMACEUTICALS INC 0.6%

Value ($000) $6 Shares 1,431,058 Est. Cost $15.48 Unrealized —

— THIRD HARMONIC BIO INC 0.6%

Value ($000) $5 Shares 1,151,657 Est. Cost $18.97 Unrealized —

NAUT NAUTILUS BIOTECHNOLOGY INC 0.4%

Value ($000) $4 Shares 2,000,000 Est. Cost $10.83 Unrealized -82.2%

IVVD INVIVYD INC 0.3%

Value ($000) $3 Shares 1,937,207 Est. Cost $37.11 Unrealized -92.5%

— APTINYX INC 0.3%

Value ($000) $3 Shares 8,891,758 Est. Cost $8.16 Unrealized —

— AEGLEA BIOTHERAPEUTICS INC 0.3%

Value ($000) $2 Shares 5,347,689 Est. Cost $5.13 Unrealized —

NAMSW NEWAMSTERDAM PHARMA COMPANY 0.0%

Value ($000) $0 Shares 100,000 Est. Cost $0.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SPRINGWORKS THERAPEUTICS INC	4,831,307	$126	14.0%	$21.68	—	COM	85205L107
NUVL	NUVALENT INC	3,577,267	$107	11.9%	$28.96	-3.7%	COM	670703107
NAMS	NEWAMSTERDAM PHARMA COMPANY	8,300,000	$90	10.1%	$9.95	0.0%	ORDINARY SHARES	N62509109
NTRA	NATERA INC	1,400,000	$56	6.3%	$41.20	0.0%	COM	632307104
—	MERSANA THERAPEUTICS INC	8,663,673	$51	5.7%	$12.65	—	COM	59045L106
ARQT	ARCUTIS BIOTHERAPEUTICS INC	3,000,000	$44	5.0%	$26.87	-35.0%	COM	03969K108
CRNX	CRINETICS PHARMACEUTICALS IN	2,305,558	$42	4.7%	$18.69	-5.7%	COM	22663K107
—	DYNAVAX TECHNOLOGIES CORP	3,915,000	$42	4.7%	$9.83	—	COM NEW	268158201
PHVS	PHARVARIS N V	3,180,601	$36	4.0%	$31.46	-83.3%	COM	N69605108
—	CARA THERAPEUTICS INC	2,696,030	$29	3.2%	$8.97	—	COM	140755109
PTGX	PROTAGONIST THERAPEUTICS INC	2,364,410	$26	2.9%	$11.93	-29.3%	COM	74366E102
ANNX	ANNEXON INC	4,886,616	$25	2.8%	$17.41	-68.4%	COM	03589W102
—	EQRX INC	10,003,573	$25	2.8%	$6.82	—	COM	26886C107
—	CTI BIOPHARMA CORP	3,777,308	$23	2.5%	$0.01	—	COM	12648L601
NRIX	NURIX THERAPEUTICS INC	1,822,883	$20	2.2%	$21.10	-42.9%	COM	67080M103
SVRA	SAVARA INC	11,622,598	$18	2.0%	$1.49	-7.8%	COM	805111101
SLDB	SOLID BIOSCIENCES INC	3,130,422	$17	1.9%	$6.55	0.0%	COM NEW	83422E204
TNGX	TANGO THERAPEUTICS INC	1,921,790	$14	1.6%	$11.99	-41.3%	COM	87583X109
—	2SEVENTY BIO INC	1,408,901	$13	1.5%	$18.15	—	COMMON STOCK	901384107
—	X4 PHARMACEUTICALS INC	12,202,510	$12	1.4%	$2.41	—	COM	98420X103
AVIR	ATEA PHARMACEUTICALS INC	2,485,638	$12	1.3%	$32.23	-84.3%	COM	04683R106
ACAD	ACADIA PHARMACEUTICALS INC	701,402	$11	1.2%	$18.25	-14.3%	COM	004225108
CCCC	C4 THERAPEUTICS INC	1,642,210	$10	1.1%	$29.00	-71.4%	COM STK	12529R107
RPID	RAPID MICRO BIOSYSTEMS INC	8,434,560	$10	1.1%	$20.66	-88.3%	CLASS A COM	75340L104
SYRS	SYROS PHARMACEUTICALS INC	2,124,694	$8	0.9%	$6.27	-30.8%	COM NEW	87184Q206
XLO	XILIO THERAPEUTICS INC	2,805,413	$8	0.8%	$17.03	-85.9%	COM	98422T100
—	MARINUS PHARMACEUTICALS INC	1,431,058	$6	0.6%	$15.48	—	COM NEW	56854Q200
—	THIRD HARMONIC BIO INC	1,151,657	$5	0.6%	$18.97	—	COM	88427A107
NAUT	NAUTILUS BIOTECHNOLOGY INC	2,000,000	$4	0.4%	$10.83	-82.2%	COM	63909J108
IVVD	INVIVYD INC	1,937,207	$3	0.3%	$37.11	-92.5%	COM	00534A102
—	APTINYX INC	8,891,758	$3	0.3%	$8.16	—	COM	03836N103
—	AEGLEA BIOTHERAPEUTICS INC	5,347,689	$2	0.3%	$5.13	—	COM	00773J103
NAMSW	NEWAMSTERDAM PHARMA COMPANY	100,000	$0	0.0%	$0.00	—	*W EXP 11/22/202	N62509117